IE58269B1 - A therapeutically useful compound - Google Patents
A therapeutically useful compoundInfo
- Publication number
- IE58269B1 IE58269B1 IE302485A IE302485A IE58269B1 IE 58269 B1 IE58269 B1 IE 58269B1 IE 302485 A IE302485 A IE 302485A IE 302485 A IE302485 A IE 302485A IE 58269 B1 IE58269 B1 IE 58269B1
- Authority
- IE
- Ireland
- Prior art keywords
- compound
- sedative
- dogs
- analgesic
- therapeutically useful
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title description 14
- 239000000730 antalgic agent Substances 0.000 claims abstract description 5
- 241000124008 Mammalia Species 0.000 claims abstract 2
- CUHVIMMYOGQXCV-UHFFFAOYSA-N medetomidine Chemical compound C=1C=CC(C)=C(C)C=1C(C)C1=CNC=N1 CUHVIMMYOGQXCV-UHFFFAOYSA-N 0.000 claims abstract 2
- 241000282472 Canis lupus familiaris Species 0.000 claims description 12
- 230000001624 sedative effect Effects 0.000 claims description 8
- 239000000932 sedative agent Substances 0.000 claims description 7
- 241000282326 Felis catus Species 0.000 claims description 5
- 230000000202 analgesic effect Effects 0.000 claims description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 241000700198 Cavia Species 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 6
- BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 6
- 229960001600 xylazine Drugs 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- RHDJRPPFURBGLQ-UHFFFAOYSA-N detomidine Chemical compound CC1=CC=CC(CC=2NC=NC=2)=C1C RHDJRPPFURBGLQ-UHFFFAOYSA-N 0.000 description 5
- 206010039897 Sedation Diseases 0.000 description 3
- 229960001894 detomidine Drugs 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000036280 sedation Effects 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- OIWRDXKNDCJZSM-UHFFFAOYSA-N 5-[(2,3-dimethylphenyl)methyl]-1h-imidazole;hydron;chloride Chemical compound Cl.CC1=CC=CC(CC=2NC=NC=2)=C1C OIWRDXKNDCJZSM-UHFFFAOYSA-N 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229960002273 detomidine hydrochloride Drugs 0.000 description 1
- 229940035564 duration Drugs 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Photoreceptors In Electrophotography (AREA)
- Stringed Musical Instruments (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI844786A FI844786A0 (fi) | 1984-12-04 | 1984-12-04 | Terapeutiskt utnyttjbar foerening. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE853024L IE853024L (en) | 1986-06-04 |
| IE58269B1 true IE58269B1 (en) | 1993-08-25 |
Family
ID=8520010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE302485A IE58269B1 (en) | 1984-12-04 | 1985-12-02 | A therapeutically useful compound |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4670455A (enExample) |
| EP (1) | EP0187471B1 (enExample) |
| JP (1) | JPS61134314A (enExample) |
| AT (1) | ATE65694T1 (enExample) |
| AU (1) | AU572364B2 (enExample) |
| DE (1) | DE3583670D1 (enExample) |
| DK (1) | DK163960C (enExample) |
| FI (1) | FI844786A0 (enExample) |
| IE (1) | IE58269B1 (enExample) |
| NZ (1) | NZ213604A (enExample) |
| ZA (1) | ZA858416B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI864570A0 (fi) * | 1986-11-11 | 1986-11-11 | Farmos Oy | Terapeutiskt anvaendbar foerening. |
| GB2206880B (en) | 1987-07-16 | 1991-04-24 | Farmos Oy | Optical isomers of an imidazole derivative |
| US5344840A (en) * | 1988-02-29 | 1994-09-06 | Orion-Yhtyma Oy | 4-substituted imidazole derivatives useful in perioperative care |
| GB2215206B (en) * | 1988-02-29 | 1991-07-03 | Farmos Oy | 4-substituted imidazole derivatives useful in perioperative care |
| US5124157A (en) * | 1989-08-18 | 1992-06-23 | Cygnus Therapeutic Systems | Method and device for administering dexmedetomidine transdermally |
| AR015744A1 (es) * | 1998-04-01 | 2001-05-16 | Orion Corp | Uso de dexmedetomidina para sedacion en terapia intensiva |
| FI20041425A0 (fi) * | 2004-11-05 | 2004-11-05 | Orion Corp | Transmukosaalinen veterinäärinen koostumus |
| US7795263B2 (en) * | 2008-07-08 | 2010-09-14 | Wildlife Laboratories, Inc. | Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals |
| US20100196286A1 (en) * | 2008-12-01 | 2010-08-05 | Armer Thomas A | Inhalation delivery methods and devices |
| US8555875B2 (en) | 2008-12-23 | 2013-10-15 | Map Pharmaceuticals, Inc. | Inhalation devices and related methods for administration of sedative hypnotic compounds |
| US20130096170A1 (en) | 2011-10-14 | 2013-04-18 | Hospira, Inc. | Methods of treating pediatric patients using dexmedetomidine |
| WO2013069025A1 (en) | 2011-11-11 | 2013-05-16 | Neon Laboratories Ltd. | "process for the preparation of dexmedetomidine" |
| US8242158B1 (en) | 2012-01-04 | 2012-08-14 | Hospira, Inc. | Dexmedetomidine premix formulation |
| KR20180095732A (ko) | 2013-10-07 | 2018-08-27 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 비진정량의 덱스메데토미딘의 경피 전달을 위한 방법 및 조성물 |
| CN106456561B (zh) | 2013-10-07 | 2020-02-28 | 帝国制药美国公司 | 使用右旋美托咪啶经皮组合物治疗注意力缺陷多动症、焦虑症和失眠症的方法和组合物 |
| EP3054932B1 (en) | 2013-10-07 | 2020-12-09 | Teikoku Pharma USA, Inc. | Dexmedetomidine transdermal delivery devices and methods for using the same |
| US9717796B1 (en) | 2016-04-20 | 2017-08-01 | Slypharma, Llc | Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container |
| SG10202107367SA (en) | 2016-12-31 | 2021-08-30 | Bioxcel Therapeutics Inc | Use of sublingual dexmedetomidine for the treatment of agitation |
| BR112020026672A2 (pt) | 2018-06-27 | 2021-03-30 | Bioxcel Therapeutics, Inc. | Formulações de filme contendo dexmedetomidina e métodos para produzi-las |
| US11160791B2 (en) | 2018-11-01 | 2021-11-02 | Medefil, Inc. | Dexmedetomidine injection premix formulation in ready to use (RTU) bags |
| CA3145388A1 (en) | 2019-07-19 | 2021-01-28 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
| US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2092569B (en) * | 1981-02-05 | 1984-09-19 | Farmos Oy | Substituted imidazole derivatives and their preparation and use |
| GB2096987B (en) * | 1981-04-22 | 1984-04-04 | Farmos Oy | Substituted imidazole and imidazole derivatives and their preparation and use |
| GB2101114B (en) * | 1981-07-10 | 1985-05-22 | Farmos Group Ltd | Substituted imidazole derivatives and their preparation and use |
| EP0106060B1 (en) * | 1982-08-14 | 1988-09-28 | The Wellcome Foundation Limited | Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations |
-
1984
- 1984-12-04 FI FI844786A patent/FI844786A0/fi not_active Application Discontinuation
-
1985
- 1985-09-25 NZ NZ213604A patent/NZ213604A/xx unknown
- 1985-11-01 ZA ZA858416A patent/ZA858416B/xx unknown
- 1985-11-05 DK DK508985A patent/DK163960C/da not_active IP Right Cessation
- 1985-11-15 AU AU49971/85A patent/AU572364B2/en not_active Expired
- 1985-12-02 EP EP85308748A patent/EP0187471B1/en not_active Expired - Lifetime
- 1985-12-02 IE IE302485A patent/IE58269B1/en not_active IP Right Cessation
- 1985-12-02 DE DE8585308748T patent/DE3583670D1/de not_active Expired - Lifetime
- 1985-12-02 AT AT85308748T patent/ATE65694T1/de not_active IP Right Cessation
- 1985-12-03 JP JP60272380A patent/JPS61134314A/ja active Granted
- 1985-12-03 US US06/804,197 patent/US4670455A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU572364B2 (en) | 1988-05-05 |
| EP0187471A2 (en) | 1986-07-16 |
| FI844786A0 (fi) | 1984-12-04 |
| JPH0465050B2 (enExample) | 1992-10-16 |
| DK163960C (da) | 1992-09-21 |
| DK508985D0 (da) | 1985-11-05 |
| DK508985A (da) | 1986-06-05 |
| NZ213604A (en) | 1988-09-29 |
| AU4997185A (en) | 1986-06-12 |
| IE853024L (en) | 1986-06-04 |
| JPS61134314A (ja) | 1986-06-21 |
| DE3583670D1 (de) | 1991-09-05 |
| US4670455A (en) | 1987-06-02 |
| ZA858416B (en) | 1986-07-30 |
| ATE65694T1 (de) | 1991-08-15 |
| EP0187471A3 (en) | 1988-09-14 |
| DK163960B (da) | 1992-04-27 |
| EP0187471B1 (en) | 1991-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE58269B1 (en) | A therapeutically useful compound | |
| Pippi et al. | Objective tests of analgesic drugs in ponies | |
| Clarke et al. | Medetomidine, a new sedative‐analgesic for use in the dog and its reversal with atipamezole | |
| DE60009346T2 (de) | Buprenorphin enthaltende analgetische zusammensetzungen | |
| Dodman et al. | Use of narcotic antagonists to modify stereotypic self-licking, self-chewing, and scratching behavior in dogs | |
| RU98104448A (ru) | Оральные быстрорастворяющиеся композиции агонистов допамина | |
| Fielding et al. | Pharmacokinetics and clinical effects of a subanesthetic continuous rate infusion of ketamine in awake horses | |
| KR890001537A (ko) | 5ht-3 길항제의 용도 | |
| KR19990067527A (ko) | 동통의 치료를 위한 에피나스틴의 용도 | |
| Heppelmann et al. | Effects of acetylsalicylic acid and indomethacin on single groups III and IV sensory units from acutely inflamed joints | |
| Huang et al. | Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens | |
| WO2003009805A2 (en) | Analgesic methods using endothelin receptor ligands | |
| Müller et al. | Effect of butorphanol, midazolam or ketamine on romifidine based sedation in horses during standing cheek tooth removal | |
| Harto et al. | Doxepin in the treatment of chronic urticaria | |
| LeBlanc | Chemical restraint for surgery in the standing horse | |
| JP4867123B2 (ja) | 神経因性疼痛治療剤および神経因性疼痛のモデル動物 | |
| IL291823A (en) | Methods and materials for treating neurotoxicity | |
| Vaha‐Vahe | Clinical effectiveness of atipamezole as a medetomidine antagonist in cats | |
| EP0176309A2 (en) | Use of N-(2-aminocyclohexyl)benzeneacetamides in the treatment of cerebral ischemia | |
| EP0236477B1 (en) | Use of 6-methylene-6-desoxy-n-cyclopropylmethyl-14-hydroxydihydronormorphine | |
| RU2208013C2 (ru) | ПРОИЗВОДНЫЕ 8-ЗАМЕЩЕННОГО-9H-1,3-ДИОКСОЛ/4,5-h//2,3/БЕНЗОДИАЗЕПИНА, ЯВЛЯЮЩИЕСЯ ИНГИБИТОРАМИ AMPA/КАИНАТНОГО РЕЦЕПТОРА, СПОСОБ ИХ ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ | |
| SK5812000A3 (en) | Method of reducing craving in mammals | |
| Celozzi et al. | An animal model for assessing pain-on-injection of antibiotics | |
| Vainio | Detomidine hydrochloride. A novel imidazole-type sedative analgesic | |
| Scurr et al. | Trials of perphenazine in the prevention of post-operative vomiting |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK9A | Patent expired |